Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen, Gentris to Co-Develop SNP Assays

NEW YORK, Feb. 7 - Nanogen and Gentris, a clinical pharmacogenomics testing and diagnostics company, have partnered to study drug-metabolizing enzymes and transporter markers, the firms said jointly on Thursday.

 

Terms of the open-ended deal call for Nanogen to provide its NanoChip molecular biology workstation to Gentris, which will use it to develop certain SNP assays.

 

Gentris brings to the table its "experience in clinical application methodology to be able to apply it to [Nanogen's] platform," a Gentris spokeswoman said.

 

Nanogen will have exclusive rights to commercialize any assays that are developed and will shell out "certain payments" to Gentris if it happens to sell the assays after receiving approval from the US Food and Drug Administration, the companies said.

 

Further financial details of the agreement were not disclosed.

 

Nanogen hope that the deal will help it "develop and commercialize ... new tests ... and allow us to enter the clinical pharmacogenomic market," Randy White, Nanogen's CEO, said in a statement.

 

In November last year, Gentris partnered with MDS Pharma Services to establish a genomic database of genotyped volunteers and diagnostic reference controls.

 

Terms of that agreement call for Gentris to genotype individuals for genes associated with drug metabolism for MDS' gene library. In return, Gentris will gain access to the library, whose samples "will be immediately commercialized" by Gentris and an undisclosed number of collaborators as pharmacogenomic diagnostics.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.